← Marsh & McLennan Companies overview

Marsh & McLennan Companies vs Brown & Brown: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Marsh & McLennan Companies, Inc. (MRSH)

Q3 2026
▲3

Marsh grows on health-cost demand, buybacks, AI push despite falling insurance rates

  • Q2 beat, buybacks and 10% dividend hike Marsh reported 6% revenue growth and 9% higher adjusted EPS, bought back $750 million of stock and raised its dividend 10% for a 17th straight year. Steady profit and cash returned to shareholders support the share price.

    The quarter's results and capital returns are the core new financial facts driving the stock.

  • Health-cost surge lifts benefits consulting demand Marsh's survey projects US employer health costs will jump 8.2% in 2027, the steepest since 2003. Rising costs push employers to seek Marsh's benefits advice, supporting demand for its consulting business and its revenue outlook.

    This is the period's biggest demand driver for Marsh's consulting arm.

  • Falling insurance rates offset by AI and new services Commercial insurance rates fell 6% and property rates 12%, a headwind to brokerage commissions. Marsh is countering with AI tools like Risk Companion and new offerings such as Archer, which add recurring service revenue and broaden its mix.

    It captures the main negative force on pricing and the company's response.

  • Analysts see 2026 earnings up 7.1% Zacks notes rising 2026 earnings estimates, a $5.5 billion capital deployment plan and management consulting growing 13.4% organically, its fastest in over two years. Upward revisions and expected Q3 beat support the stock.

    Analyst estimate momentum and capital plans are a key forward-looking driver.

August 2026
▲3

Marsh grows on health-cost demand, buybacks, AI push despite falling insurance rates

  • Q2 beat, buybacks and 10% dividend hike Marsh reported 6% revenue growth and 9% higher adjusted EPS, bought back $750 million of stock and raised its dividend 10% for a 17th straight year. Steady profit and cash returned to shareholders support the share price.

    The quarter's results and capital returns are the core new financial facts driving the stock.

  • Health-cost surge lifts benefits consulting demand Marsh's survey projects US employer health costs will jump 8.2% in 2027, the steepest since 2003. Rising costs push employers to seek Marsh's benefits advice, supporting demand for its consulting business and its revenue outlook.

    This is the period's biggest demand driver for Marsh's consulting arm.

  • Falling insurance rates offset by AI and new services Commercial insurance rates fell 6% and property rates 12%, a headwind to brokerage commissions. Marsh is countering with AI tools like Risk Companion and new offerings such as Archer, which add recurring service revenue and broaden its mix.

    It captures the main negative force on pricing and the company's response.

  • Analysts see 2026 earnings up 7.1% Zacks notes rising 2026 earnings estimates, a $5.5 billion capital deployment plan and management consulting growing 13.4% organically, its fastest in over two years. Upward revisions and expected Q3 beat support the stock.

    Analyst estimate momentum and capital plans are a key forward-looking driver.

Latest
▲3

Marsh grows on health-cost demand, buybacks, AI push despite falling insurance rates

  • Q2 beat, buybacks and 10% dividend hike Marsh reported 6% revenue growth and 9% higher adjusted EPS, bought back $750 million of stock and raised its dividend 10% for a 17th straight year. Steady profit and cash returned to shareholders support the share price.

    The quarter's results and capital returns are the core new financial facts driving the stock.

  • Health-cost surge lifts benefits consulting demand Marsh's survey projects US employer health costs will jump 8.2% in 2027, the steepest since 2003. Rising costs push employers to seek Marsh's benefits advice, supporting demand for its consulting business and its revenue outlook.

    This is the period's biggest demand driver for Marsh's consulting arm.

  • Falling insurance rates offset by AI and new services Commercial insurance rates fell 6% and property rates 12%, a headwind to brokerage commissions. Marsh is countering with AI tools like Risk Companion and new offerings such as Archer, which add recurring service revenue and broaden its mix.

    It captures the main negative force on pricing and the company's response.

  • Analysts see 2026 earnings up 7.1% Zacks notes rising 2026 earnings estimates, a $5.5 billion capital deployment plan and management consulting growing 13.4% organically, its fastest in over two years. Upward revisions and expected Q3 beat support the stock.

    Analyst estimate momentum and capital plans are a key forward-looking driver.

Brown & Brown Inc (BRO)

Q3 2026
▲3

AI push and deal-driven growth offset weak organic revenue

  • AI-first overhaul with Anthropic, McKinsey, Accenture Brown & Brown is rolling out AI across all 23,000 staff with outside partners, targeting faster workflows and up to 2x-8x productivity gains in early tests. If it works, it should lift profit margins over the next few years, which supports the stock price.

    This is the main new strategic driver of future earnings and the biggest positive force in the period.

  • Q2 revenue beat on growth but organic sales slipped Second-quarter revenue rose 30.4% to about $1.7 billion, mostly from acquisitions, but organic revenue fell 0.7% and missed analyst estimates. Adjusted profit matched expectations. The weak underlying growth is a real counterweight to the headline growth story.

    It shows the core business is not growing on its own, which tempers the positive acquisition-driven numbers.

  • Cost savings and buybacks support per-share value Management expects $30-40 million of cost savings this year from recent deals, and the company bought back $250 million of stock while raising its dividend 10%. Fewer shares and lower costs help per-share earnings even when revenue growth is uneven.

    These capital actions directly support the stock price and are new details from the quarter.

  • Canada expansion of Marcus & Millichap partnership Brown & Brown's preferred partner program with Marcus & Millichap expanded into Canada, giving its commercial real estate clients access to Brown & Brown's insurance and risk services. This opens a new source of customer demand outside the U.S.

    It is a fresh demand-side growth avenue that could add revenue over time.

August 2026
▲3

AI push and deal-driven growth offset weak organic revenue

  • AI-first overhaul with Anthropic, McKinsey, Accenture Brown & Brown is rolling out AI across all 23,000 staff with outside partners, targeting faster workflows and up to 2x-8x productivity gains in early tests. If it works, it should lift profit margins over the next few years, which supports the stock price.

    This is the main new strategic driver of future earnings and the biggest positive force in the period.

  • Q2 revenue beat on growth but organic sales slipped Second-quarter revenue rose 30.4% to about $1.7 billion, mostly from acquisitions, but organic revenue fell 0.7% and missed analyst estimates. Adjusted profit matched expectations. The weak underlying growth is a real counterweight to the headline growth story.

    It shows the core business is not growing on its own, which tempers the positive acquisition-driven numbers.

  • Cost savings and buybacks support per-share value Management expects $30-40 million of cost savings this year from recent deals, and the company bought back $250 million of stock while raising its dividend 10%. Fewer shares and lower costs help per-share earnings even when revenue growth is uneven.

    These capital actions directly support the stock price and are new details from the quarter.

  • Canada expansion of Marcus & Millichap partnership Brown & Brown's preferred partner program with Marcus & Millichap expanded into Canada, giving its commercial real estate clients access to Brown & Brown's insurance and risk services. This opens a new source of customer demand outside the U.S.

    It is a fresh demand-side growth avenue that could add revenue over time.

Latest
▲3

AI push and deal-driven growth offset weak organic revenue

  • AI-first overhaul with Anthropic, McKinsey, Accenture Brown & Brown is rolling out AI across all 23,000 staff with outside partners, targeting faster workflows and up to 2x-8x productivity gains in early tests. If it works, it should lift profit margins over the next few years, which supports the stock price.

    This is the main new strategic driver of future earnings and the biggest positive force in the period.

  • Q2 revenue beat on growth but organic sales slipped Second-quarter revenue rose 30.4% to about $1.7 billion, mostly from acquisitions, but organic revenue fell 0.7% and missed analyst estimates. Adjusted profit matched expectations. The weak underlying growth is a real counterweight to the headline growth story.

    It shows the core business is not growing on its own, which tempers the positive acquisition-driven numbers.

  • Cost savings and buybacks support per-share value Management expects $30-40 million of cost savings this year from recent deals, and the company bought back $250 million of stock while raising its dividend 10%. Fewer shares and lower costs help per-share earnings even when revenue growth is uneven.

    These capital actions directly support the stock price and are new details from the quarter.

  • Canada expansion of Marcus & Millichap partnership Brown & Brown's preferred partner program with Marcus & Millichap expanded into Canada, giving its commercial real estate clients access to Brown & Brown's insurance and risk services. This opens a new source of customer demand outside the U.S.

    It is a fresh demand-side growth avenue that could add revenue over time.